Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $100 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky maintains an Outperform rating on Merit Medical Systems (NASDAQ:MMSI) with a $100 price target.
July 16, 2024 | 1:13 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barrington Research analyst Michael Petusky maintains an Outperform rating on Merit Medical Systems (NASDAQ:MMSI) with a $100 price target.
The reaffirmation of an Outperform rating and a $100 price target by Barrington Research is a positive signal for investors, likely boosting short-term confidence and potentially driving the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100